tradingkey.logo

Thermo Fisher Scientific Inc

TMO
567.390USD
+11.170+2.01%
Close 10/31, 16:00ETQuotes delayed by 15 min
214.25BMarket Cap
32.61P/E TTM

Thermo Fisher Scientific Inc

567.390
+11.170+2.01%

More Details of Thermo Fisher Scientific Inc Company

Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.

Thermo Fisher Scientific Inc Info

Ticker SymbolTMO
Company nameThermo Fisher Scientific Inc
IPO dateAug 27, 1980
CEOMr. Marc N. Casper
Number of employees125000
Security typeOrdinary Share
Fiscal year-endAug 27
Address168 Third Avenue
CityWALTHAM
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code02451
Phone17816221000
Websitehttps://www.thermofisher.com/
Ticker SymbolTMO
IPO dateAug 27, 1980
CEOMr. Marc N. Casper

Company Executives of Thermo Fisher Scientific Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.52K
-2.05%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
-3.05%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
13.47K
-2.38%
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
12.74K
-7.01%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
11.48K
-3.37%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.62K
+7.01%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.52K
-2.05%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
-3.05%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
13.47K
-2.38%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
By RegionUSD
Name
Revenue
Proportion
North America
5.72B
52.71%
Europe
2.83B
26.07%
Asia Pacific
1.92B
17.69%
Other Regions
383.00M
3.53%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%

Shareholding Stats

Updated: Thu, Oct 30
Updated: Thu, Oct 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.90%
BlackRock Institutional Trust Company, N.A.
4.49%
State Street Investment Management (US)
4.36%
Capital World Investors
2.54%
Geode Capital Management, L.L.C.
2.15%
Other
77.56%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.90%
BlackRock Institutional Trust Company, N.A.
4.49%
State Street Investment Management (US)
4.36%
Capital World Investors
2.54%
Geode Capital Management, L.L.C.
2.15%
Other
77.56%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.55%
Investment Advisor/Hedge Fund
28.60%
Hedge Fund
3.10%
Bank and Trust
3.00%
Research Firm
2.94%
Pension Fund
2.68%
Sovereign Wealth Fund
1.87%
Family Office
0.21%
Family Office
0.20%
Other
7.84%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
4325
347.19M
91.94%
-6.74M
2025Q2
4335
351.93M
93.19%
-4.42M
2025Q1
4395
350.27M
92.78%
-5.82M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
33.62M
8.9%
+304.63K
+0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.94M
4.49%
-335.33K
-1.94%
Jun 30, 2025
State Street Investment Management (US)
16.48M
4.36%
-58.52K
-0.35%
Jun 30, 2025
Capital World Investors
9.58M
2.54%
-1.48M
-13.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
8.11M
2.15%
-12.40K
-0.15%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
5.61M
1.49%
+1.13M
+25.29%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.59M
1.48%
-469.24K
-7.75%
Jun 30, 2025
Capital Research Global Investors
5.43M
1.44%
-2.18M
-28.62%
Jun 30, 2025
JP Morgan Asset Management
5.38M
1.43%
-1.11M
-17.11%
Jun 30, 2025
T. Rowe Price Associates, Inc.
5.00M
1.32%
-3.74M
-42.82%
Jun 30, 2025
View more

Related ETFs

Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
Monarch Blue Chips Core ETF
4.88%
Honeytree US Equity ETF
4.24%
VanEck Morningstar Wide Moat Value ETF
3.81%
Health Care Select Sector SPDR Fund
3.74%
Proshares Ultra Health Care
3.74%
Goldman Sachs Future Health Care Equity ETF
3.69%
iShares U.S. Healthcare ETF
3.6%
AdvisorShares Focused Equity ETF
3.56%
Parnassus Value Select ETF
3.52%
Invesco Nasdaq Free Cash Flow Achievers ETF
3.39%
View more
Monarch Blue Chips Core ETF
Proportion4.88%
Honeytree US Equity ETF
Proportion4.24%
VanEck Morningstar Wide Moat Value ETF
Proportion3.81%
Health Care Select Sector SPDR Fund
Proportion3.74%
Proshares Ultra Health Care
Proportion3.74%
Goldman Sachs Future Health Care Equity ETF
Proportion3.69%
iShares U.S. Healthcare ETF
Proportion3.6%
AdvisorShares Focused Equity ETF
Proportion3.56%
Parnassus Value Select ETF
Proportion3.52%
Invesco Nasdaq Free Cash Flow Achievers ETF
Proportion3.39%

Dividend

A total of 2.29B USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Feb 22, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Apr 14, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 14, 2023
Mar 14, 2023
Nov 10, 2022
TMO.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 16, 2023 going ex on Dec 14, 2022
Dec 15, 2022
Jan 16, 2023
Dec 14, 2022
View more

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI